Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor 2024-06-28
  2. Engineered commensal bacteria prevent systemic inflammation-induced memory impairment and amyloidogenesis via producing GLP-1 2018-06-28

Studies

2 studies carry this tag.

Date range

2018 to 2024

Top journals

  • Applied microbiology and biotechnology 1
  • Science (New York, N.Y.) 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Science (New York, N.Y.) 2024-06-28 Genetics

    Prion disease is caused by misfolding of the prion protein (PrP) into pathogenic self-propagating conformations, leading to rapid-onset dementia and death.

  2. Engineered commensal bacteria prevent systemic inflammation-induced memory impairment and amyloidogenesis via producing GLP-1

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Applied microbiology and biotechnology 2018-06-28 Drug development

    The anti-obesity drug GLP-1 has been proven to have an impact on central nervous system, while its extremely short half-life greatly limited its use.

All topic tags with their study counts